Trial · NCT01431339
Results by group16
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 16 of 16
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Early Clinical Efficacy | Dalbavancin | Clinical Responder | 285 | participants | |
| Early Clinical Efficacy | Vancomycin With Possible Switch to Oral Linezolid | Clinical Responder | 288 | participants | |
| Early Clinical Efficacy | Dalbavancin | Clinical Non-Responder | 86 | participants | |
| Early Clinical Efficacy | Vancomycin With Possible Switch to Oral Linezolid | Clinical Non-Responder | 80 | participants | |
| Clinical Status | Dalbavancin | Clinical Succcess | 303 | participants | |
| Clinical Status | Vancomycin With Possible Switch to Oral Linezolid | Clinical Succcess | 280 | participants | |
| Clinical Status | Dalbavancin | Clinical Failure | 21 | participants | |
| Clinical Status | Vancomycin With Possible Switch to Oral Linezolid | Clinical Failure | 22 | participants | |
| >= 20% Reduction in Lesion Area | Dalbavancin | Clinical Responder | 325 | participants | |
| >= 20% Reduction in Lesion Area | Vancomycin With Possible Switch to Oral Linezolid | Clinical Responder | 316 | participants | |
| >= 20% Reduction in Lesion Area | Dalbavancin | Clinical Non-Responder | 46 | participants | |
| >= 20% Reduction in Lesion Area | Vancomycin With Possible Switch to Oral Linezolid | Clinical Non-Responder | 52 | participants | |
| Clinical Status | Dalbavancin | Clinical Success | 283 | participants | |
| Clinical Status | Vancomycin With Possible Switch to Oral Linezolid | Clinical Success | 257 | participants | |
| Clinical Status | Dalbavancin | Clinical Failure | 11 | participants | |
| Clinical Status | Vancomycin With Possible Switch to Oral Linezolid | Clinical Failure | 15 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01431339/results